Overview Safety and Efficacy of AL-15469A 0.5% / AL-6515 0.3% Ophthalmic Suspension for Treatment of Bacterial Conjunctivitis Status: Withdrawn Trial end date: 1969-12-31 Target enrollment: Participant gender: Summary To assess safety and efficacy of AL-15469A 0.5% /AL-6515 0.3% Ophthalmic Suspension for treatment of bacterial conjunctivitis Phase: Phase 2 Details Lead Sponsor: Alcon Research